Vanguard Group
SONN icon

Vanguard Group’s Sonnet BioTherapeutics SONN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,726
Closed -$13.8K 4378
2024
Q2
$13.8K Hold
14,726
﹤0.01% 4378
2024
Q1
$27.4K Hold
14,726
﹤0.01% 4367
2023
Q4
$25.6K Buy
14,726
+100
+0.7% +$174 ﹤0.01% 4426
2023
Q3
$41.9K Sell
14,626
-3,431
-19% -$9.83K ﹤0.01% 4431
2023
Q2
$8.85K Hold
18,057
﹤0.01% 4537
2023
Q1
$6.5K Hold
18,057
﹤0.01% 4548
2022
Q4
$20.8K Sell
18,057
-115,754
-87% -$133K ﹤0.01% 4494
2022
Q3
$197K Sell
133,811
-1,754,176
-93% -$2.58M ﹤0.01% 4420
2022
Q2
$529K Buy
1,887,987
+206,202
+12% +$57.8K ﹤0.01% 4280
2022
Q1
$632K Sell
1,681,785
-95,168
-5% -$35.8K ﹤0.01% 4336
2021
Q4
$734K Buy
1,776,953
+200
+0% +$83 ﹤0.01% 4349
2021
Q3
$1.08M Buy
1,776,753
+1,075,119
+153% +$652K ﹤0.01% 4231
2021
Q2
$1.11M Buy
701,634
+565,671
+416% +$894K ﹤0.01% 4130
2021
Q1
$306K Hold
135,963
﹤0.01% 4206
2020
Q4
$303K Buy
135,963
+47,125
+53% +$105K ﹤0.01% 4036
2020
Q3
$228K Buy
+88,838
New +$228K ﹤0.01% 3940
2020
Q2
Sell
-22,675
Closed -$9K 4089
2020
Q1
$9K Buy
22,675
+2,700
+14% +$1.07K ﹤0.01% 4073
2019
Q4
$12K Hold
19,975
﹤0.01% 4110
2019
Q3
$14K Hold
19,975
﹤0.01% 4139
2019
Q2
$22K Hold
19,975
﹤0.01% 4146
2019
Q1
$35K Hold
19,975
﹤0.01% 4082
2018
Q4
$26K Sell
19,975
-539
-3% -$702 ﹤0.01% 4110
2018
Q3
$51K Hold
20,514
﹤0.01% 4126
2018
Q2
$63K Hold
20,514
﹤0.01% 4089
2018
Q1
$76K Buy
20,514
+3,047
+17% +$11.3K ﹤0.01% 4052
2017
Q4
$46K Sell
17,467
-1,332
-7% -$3.51K ﹤0.01% 4033
2017
Q3
$49K Buy
18,799
+1
+0% +$3 ﹤0.01% 4030
2017
Q2
$59K Sell
18,798
-199,075
-91% -$625K ﹤0.01% 4018
2017
Q1
$78K Hold
217,873
﹤0.01% 3999
2016
Q4
$90K Hold
217,873
﹤0.01% 3981
2016
Q3
$120K Hold
217,873
﹤0.01% 3965
2016
Q2
$94K Hold
217,873
﹤0.01% 4029
2016
Q1
$176K Hold
217,873
﹤0.01% 3970
2015
Q4
$218K Buy
217,873
+9,009
+4% +$9.01K ﹤0.01% 4006
2015
Q3
$229K Buy
208,864
+125,639
+151% +$138K ﹤0.01% 4014
2015
Q2
$205K Buy
+83,225
New +$205K ﹤0.01% 4043